Bioelectronic Medicine

Selected news for the healthcare topic - Bioelectronic Medicine, collected since 10/2017. Recent stories appear in dbtnews.com and MDDI. This healthcare topic shares news with Medical Research, electroCore, Northwell Health, Kevin J. Tracey and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/6/2021 Feinstein Institutes Receives $3.7M NIH Support for Bioelectronic Medicine Research | Financial Buzz financialbuzz.com The Feinstein Institutes for Medical Research , the global scientific home of bioelectronic medicine , has been awarded a five-year grant totaling more than $3.7 million from the National Institutes of Health’s (NIH) National Institute of General Medical Sciences (NIGMS) to support research in the molecular basis of bioelectronic medicine. Kevin J. Tracey, MD , president and CEO of the Feinstein Institutes, is the principal investigator leading the research.This press ...
4/20/2021 Deer Park Tribune dptribune.com ROCKAWAY, NJ, April 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. ( Nasdaq: ECOR ), a commercial-stage bioelectronic medicine company, today announced it has entered into an agreement with East Agency to serve as the exclusive distributor of the gammaCore Sapphire™ non-invasive vagus nerve stimulator (nVNS) to patients suffering from primary headache disorders in Qatar.“East Agency is a dedicated healthcare company focusing on high-end technologies and innovations targeting the ...
4/14/2021 The NHS Introduces Handheld Gadget To Zap Away Cluster Headaches & Migraines designtaxi.com ... worse, bouts of frequent attacks can last from weeks to months when headaches occur regularly. In the UK, cluster headaches are said to affect over 11,000 people. Hence, the National Health Service (NHS) and bioelectronic medicine company electroCore have come up with the ‘gammaCore Sapphire’– a handheld device that can be used to alleviate migraines and cluster headaches. The gammaCore is a non-drug treatment that uses non ...
4/13/2021 electroCore Provides Business Update and Select First Quarter 2021 Financial Guidance forextv.com First-quarter 2021 revenue expected to be more than $1.1 million - Net cash used for the first quarter 2021 of approximately $4.1 million ROCKAWAY, NJ, April 13, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as select unaudited preliminary financial guidance for the first quarter of 2021. “We are pleased to announce a return to ...
4/12/2021 John Rogers Named Guggenheim Fellow northwestern.edu ... traditional field of study in science and engineering, with outcomes that have changed the way people think about consumer and medical devices.Rogers will use the fellowship to continue developing wireless, bioresorbable stimulators as bioelectronic medicine .“This wonderful recognition belongs to a broad, talented collection of students and collaborators over the years — my name just happens to be attached,” Rogers said. “At a personal level, this fellowship has ...
4/9/2021 electroCore Inc. [ECOR] moved up 5.10: Why It's Important dbtnews.com electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced the top-line results from the SAVIOR-1 study, a prospective, randomized, controlled study evaluating non-invasive vagus nerve stimulation (nVNS) using gammaCore Sapphire in patients admitted to the hospital for treatment of COVID-19 between April 2020 and February 2021. This study was an investigator-initiated trial conducted at the Hospital Clínico Universitario de Valencia, Spain.It ...
4/8/2021 electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients Nasdaq:ECOR bollyinside.com Globenewswire 2021-04-08 ROCKAWAY, NJ, April 08, 2021 (News) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the top-line results from the SAVIOR-1 study, a prospective, randomized, controlled study evaluating non-invasive vagus nerve stimulation (nVNS) using gammaCore Sapphire in patients admitted to the hospital for treatment of COVID-19 between April 2020 and February 2021. This study was an investigator-initiated trial conducted ...
4/5/2021 GE & Feinstein Liver Stim Provides New Pathway in Bioelectronic Medicine to Treat Obesity MDDI GE & Feinstein Liver Stim Provides New Pathway in Bioelectronic Medicine to Treat Obesity Africa Studio - stock.adobe.com Katie Pfaff Apr 05, 2021Preclinical research from Feinstein Institutes and GE Research uses a noninvasive targeted stimulation of the liver to reduce obesity, and potentially Type 2 diabetes mellitus. The peripheral ultrasound stimulation (pFUS) device interrupts inflammation, the potential chemical culprit in obesity and metabolic diseases.Obesity impacts nearly half the U.S., at ...
4/5/2021 electroCore, Inc. Announces Regulatory Approval in Canada - GlobeNewswire Globe Newswire Rockaway, New Jersey, UNITED STATES ROCKAWAY, NJ, April 05, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Health Canada has granted regulatory approval for the promotion and sale of the gammaCore Sapphire family of products in Canada for prevention and therapeutic treatment of migraine and cluster headache, as outlined in the registration application with Health Canada.gammaCore Sapphire will be distributed in ...
4/5/2021 Deer Park Tribune dptribune.com ROCKAWAY, NJ, April 05, 2021 (GLOBE NEWSWIRE) --electroCore, Inc. ( Nasdaq: ECOR ), a commercial-stage bioelectronic medicine company, announced today that Health Canada has granted regulatory approval for the promotion and sale of the gammaCore Sapphire family of products in Canada for prevention and therapeutic treatment of migraine and cluster headache, as outlined in the registration application with Health Canada.gammaCore Sapphire will be distributed in Canada by RSK Medical Inc ...
4/5/2021 electroCore, Inc. Announces Regulatory Approval in Canada - Financial Post financialpost.com electroCore, Inc. Announces Regulatory Approval in Canada Article content ROCKAWAY, NJ, April 05, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Health Canada has granted regulatory approval for the promotion and sale of the gammaCore Sapphire family of products in Canada for prevention and therapeutic treatment of migraine and cluster headache, as outlined in the registration application with Health Canada. gammaCore ...
4/2/2021 Bioelectronic Medicine Market By Application, Oppurtunities, Forthcoming Stratigies , Key Player, Flourishing Analysis And Future Forecast By 2026 vitalnews24.com Bioelectronic Medicine Market By Application, Oppurtunities, Forthcoming Stratigies , Key Player, Flourishing Analysis And Future Forecast By 2026 Bioelectronic Medicine Market By Application, Oppurtunities, Forthcoming Stratigies , Key Player, Flourishing Analysis And Future Forecast By 2026 Shubham Bhosale Bioelectronic Medicine Market Forecast , Bioelectronic Medicine Market Outlook , Bioelectronic Medicine Revenue Generation , Bioelectronic Medicine Trends (Jan 2020), The Latest Report on Bioelectronic Medicine Market 2020 is Analyzed on the basis of its Types and ...
4/2/2021 How Would The Bioelectronic Medicine Market Substantiate In The Next 10 Years? PRSync ... window of antidote to prevent several critical diseases.Bioelectronic medicines are not only an alternate alley of cure but is a brewing revolution which can change the entire demography of the pharmaceutical industry. The Bioelectronic medicines sans side effects and they are affordable as they depend on an alternate mode of treatment through electrical stimulation. //www.persistencemarketresearch.co/samples/13012The growth potential of this medicine is immense and they can usher ...
3/29/2021 Ultrasound Stimulation Can Reduce Obesity, Research Indicates mpo-mag.com Breaking News Ultrasound Stimulation Can Reduce Obesity, Research Indicates New study is based on the discovery that ultrasound can be used to perform peripheral nerve modulation as a new form of bioelectronic medicine . Tomas Huerta (left) and Sangeeta Chavan (right) of the Feinstein Institutes. Image courtesy of The Feinstein Institutes for Medical Research. Michael Barbella, Managing Editor 03.29.21 New research is rekindling hope in finding alternative ways to battle obesity ...
3/26/2021 Dr. Slaoui leaves 2 more drugmakers, apologizes amid sexual harassment allegations Becker's Hospital Review ... ago when he was a GlaxoSmithKline employee.GlaxoSmithKline fired Dr. Slaoui from his role as Galvani Bioelectronics' board chairman March 24 because of the allegations. Galvani Bioelectronics is a medical research company that develops bioelectronic medicine s to treat chronic conditions. It was formed in 2016 via a partnership between GlaxoSmithKline and Google life science subsidiary Verily.A March 24 SEC filing revealed Dr. Slaoui resigned as chair of Vaxcyte's board ...
3/25/2021 Health Highlights: March 25, 2021 U.S. News & World Report ... Operation Warp Speed.GSK announced Wednesday that Slaoui had been removed as chairman of the board of the medical research company Galvani Bioelectronics, a joint venture between GSK and Verily Life Sciences. Galvani develops bioelectronic medicine s to treat chronic illness, CBS News reported.After becoming aware of claims against Slaoui in February, GSK hired an outside law firm to conduct an investigation that "substantiated the allegations and is ongoing," about ...
3/25/2021 Moncef Slaoui, ex-Operation Warp Speed science chief, fired from board over sexual harassment claim - CBS News CBS News ... Slaoui is being ousted from his seat as chairman of the board of Galvani Bioelectronics, a joint venture between GSK and Verily Life Sciences. The medical research company is focused on the development of bioelectronic medicine s to treat chronic illness."Dr. Slaoui's behaviors are wholly unacceptable," GSK said. "They represent an abuse of his leadership position, violate company policies and are contrary to the strong values that define GSK's culture ...
3/24/2021 Ex-Operation Warp Speed science chief fired after harassment claim CBS News ... Slaoui is being ousted from his seat as chairman of the board of Galvani Bioelectronics, a joint venture between GSK and Verily Life Sciences. The medical research company is focused on the development of bioelectronic medicine s to treat chronic illness."Dr. Slaoui's behaviors are wholly unacceptable," GSK said. "They represent an abuse of his leadership position, violate company policies and are contrary to the strong values that define GSK's culture ...
3/24/2021 Glaxo Fires Slaoui as Startup's Chair After Harassment Inquiry - TheStreet TheStreet ... an inquiry into sexual-harassment allegations. Author: Vidhi Choudhary Publish date: Mar 24, 2021 12:43 PM EDTU.K. drugmaker GlaxoSmithKline ( GSK ) - Get Report on Wednesday said Moncef Slaoui was fired as chairman of a bioelectronic medicine unit, Galvani Bioelectronics, after an inquiry substantiated allegations of sexual harassment against him.GlaxoSmithKline said it had received a letter that alleged sexual harassment and inappropriate conduct by Slaoui toward a Glaxo employee. The ...
3/24/2021 GSK fires former U.S. vaccine head Slaoui over harassment allegation Yahoo News ... receipt of a letter containing the allegations of inappropriate conduct towards the employee of GSK, the company said. GSK said the allegations stemmed from when Slaoui was an employee of GSK. Galvani is a bioelectronic medicine s set up in 2016 by GlaxoSmithKline and verily, the life sciences unit of Google parent Alphabet.Prior to his role at Galvani, Slaoui spent nearly 30 years at GlaxoSmithKline holding various leadership roles including ...